The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients

NCT06578494 | Not Yet Recruiting

• 1 other identifier: Ultrasound IV
• Study Type: interventional
• Target: 40
• Locations: 0 countries
• Sites: N/A

Brief Summary

The purpose of this study is to investigate the clinical efficacy of nurse-performed ultrasound-guided intravenous access in oncology patients on the oncological outpatient unit in the National Hospital of the Faroe Islands.

Conditions

Supportive Care

Keywords

Ultrasonography; Intravenous; Oncology

Outcome Measures

Primary Outcomes (1)

• First attempt success rate

  Placement of a functional peripheral intravenous catheter on the first attempt. Defined as retraction of the needle, blood in the plastic catheter, smooth insertion of the plastic catheter and subsequent flush with isotonic saline without signs of extravasal placement.

  The time frame for the outcome measure first attempt succes rate for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.

Secondary Outcomes (5)

• Number of skin punctures

  The time frame for the outcome measure number of attempts for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.

• Patient's satisfaction

  The time frame for the outcome measure patient´s satisfaction for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.

• Patient's experience of pain

  The time frame for the outcome measure patient´s experience of pain for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.

• Durability

  The time frame for the outcome measure durability for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage.

• Intravenous complications

  The time frame for the outcome measure intravenous complications for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage.

Study Arms (2)

Ultrasound-guided peripheral intravenous access

EXPERIMENTAL

The patients in the experimental arm will receive ultrasound-guided peripheral intravenous catheter placement, where the dynamic needle tip (DNTP) approach (short-axis) will be used.

Device: Ultrasound

Traditional palpation intravenous access technique

ACTIVE COMPARATOR

The comparator group will receive the traditional palpation intravenous access technique.

Device: Ultrasound

Interventions

Ultrasound DEVICE

Ultrasound-guided peripheral intravenous catheter insertion

Traditional palpation intravenous access technique; Ultrasound-guided peripheral intravenous access

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may not qualify if:

• Lack of informed consent and mental incapacity.

Sponsors & Collaborators

• Faroese Hospital System: lead
• National Hospital of the Faroe Islands: collaborator
• University of the Faroe Islands: collaborator
• University of Aarhus: collaborator

MeSH Terms

Conditions

Neoplasms

Interventions

Ultrasonography

Intervention Hierarchy (Ancestors)

Diagnostic Imaging; Diagnostic Techniques and Procedures; Diagnosis

Study Officials

• Peter Juhl-Olsen, MD, PhD

  Aarhus University Hospital

  PRINCIPAL INVESTIGATOR

• August Gabriel Wang, MD, DMSc

  University of the Faroe Islands

  PRINCIPAL INVESTIGATOR

• Lisa Maria Anderssen, RN, MHS

  Department of Research, the National Hospital of the Faroe Islands

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Lisa Maria Anderssen, RN, MHS

CONTACT

(+298) 223820; lisa.anderssen1989@gmail.com

Maria Skaalum Petersen, MSc, PhD

CONTACT

(+298) 216695; maria@health.fo

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: This is a before and after study, where the patients pre-implementation stage receive intravenous access via the traditional palpation technique and in the post-implementation stage receive ultrsound-guided intravenous cannulation.

Study Record Dates

• First Submitted: August 20, 2024
• First Posted: August 29, 2024
• Study Start: September 16, 2024
• Primary Completion: October 16, 2025
• Study Completion: February 16, 2026
• Last Updated: August 29, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share